JF
KIN

Jump Financial’s Kindred Biosciences, Inc. KIN Stock Holding History

Jump Financial’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-61,668
Closed -$566K – 1668
2021
Q2 		$566K Buy
+61,668
New +$359K 0.05% 439

Other funds holding KIN

CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

Jump Financial's KIN Position: Q3 2021 in Review

Jump Financial sold out of Kindred Biosciences, Inc. (KIN) in Q3 2021, closing a stake of 61,668 shares — an estimated $566K sold.

Jump Financial first reported a position in KIN in Q2 2021 and held it in 1 quarter. The position peaked at $566K in Q2 2021. 1 fund tracked by Wall St. Rank holds KIN as of Q3 2021.

  • Jump Financial reported no remaining Kindred Biosciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Jump Financial sold 61,668 Kindred Biosciences, Inc. shares in Q3 2021, an estimated $566K.
  • Jump Financial first reported a position in Kindred Biosciences, Inc. in Q2 2021 and held it in 1 quarter.
  • Jump Financial's Kindred Biosciences, Inc. position peaked at $566K in Q2 2021.
  • 1 fund tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2021.

Based on Jump Financial's 13F filing for Q3 2021, filed 12 Nov 2021.